Author: Jackson Christopher G
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.10, Iss.7, 2001-07, pp. : 1317-1325
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Clinical Experience with Specific COX-2 Inhibitors in Arthritis
Current Pharmaceutical Design, Vol. 6, Iss. 17, 2000-11 ,pp. :
The therapeutic potential for phospholipase A2 inhibitors
Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. :
COX-2 inhibitors differ in their potential to cause ischaemic stroke
Inpharma, Vol. 1, Iss. 1553, 2006-01 ,pp. :